Top Markets
#1 ADO Protocol ADO Protocol +329.44%
#2 GoPlus Security GoPlus Security +53.12%
#3 Verus Coin Verus Coin +43.46%
#4 The Black Bull The Black Bull +42.41%
#5 Nockchain Nockchain +40.58%
#6 Starpower Starpower +35.32%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +33.57%
#8 Tutorial Tutorial +27.99%
#9 Fake World Assets Fake World Assets +25.51%
#10 GAIB AID GAIB AID +24.67%
Coin of the day
ADO Protocol ADO Protocol
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
NuCana plc NuCana plc

NuCana plc

NCNA
शेयरों में रैंक #32729
NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering... NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering advanced therapies for oncology. Its innovative product pipeline is underpinned by a proprietary ProTide technology platform. Among its key drug candidates, Acelarin is progressing through multiple clinical evaluations: a Phase I study for advanced solid tumors, Phase Ib trials for both recurrent ovarian cancer and biliary tract cancer, a Phase II trial targeting platinum-resistant ovarian cancer, and a pivotal Phase III trial for pancreatic cancer. NuCana is also developing NUC-3373, a ProTide derivative of 5-fluorouracil’s active anti-cancer metabolite. This compound is currently in a Phase I study for advanced solid tumors and a Phase Ib/2 trial for advanced colorectal cancer. Additionally, NUC-7738, a nucleoside analog, is undergoing Phase 1/2 clinical assessment for both advanced solid and hematological malignancies. To support its ProTide technology development, the company maintains research, collaboration, and licensing agreements with Cardiff University and University College Cardiff Consultants Ltd., covering the design, synthesis, characterization, and assessment of these compounds. Further collaborative and licensing arrangements are in place with Cardiff ProTides Ltd. Established in 1997, the company operated as NuCana BioMed Limited before rebranding to NuCana plc in August 2017. Its corporate headquarters are located in Edinburgh, United Kingdom.
शेयर मूल्य
$1.53
मार्केट कैप
$9.29M
बदलाव (1 दिन)
-3.77%
बदलाव (1 वर्ष)
-58.98%
देश
GB
व्यापार NuCana plc (NCNA)

श्रेणी

Healthcare
NuCana plc (NCNA) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $1.47 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $86.30K (2017-09-01 को)
NuCana plc के स्टॉक मूल्य का इतिहास 2017 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) -26.46%
2025 -98.52%
2024 -85.03%
2023 -55.23%
2022 -68.92%
2021 -46.94%
2020 -31.87%
2019 -57.91%
2018 45.00%
2017 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $515.82 31.32%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $991.05 51.58%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 7.19%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.50 13.38%
BE